 2. Supplementation with B12 in levodopa-treated PD patients with low 200 pgml or low-normal 200-300 pgml serum B12 levels is associated with significant improvement in their non-motor symptoms and reduces total plasma homocysteine concentration Hcy, a known biomarker for risk of dementia and cerebrovascular disease. 